Correlation Between Bank of America and Rekah Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Bank of America and Rekah Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Rekah Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Rekah Pharmaceutical Industry, you can compare the effects of market volatilities on Bank of America and Rekah Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Rekah Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Rekah Pharmaceutical.
Diversification Opportunities for Bank of America and Rekah Pharmaceutical
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bank and Rekah is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Rekah Pharmaceutical Industry in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rekah Pharmaceutical and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Rekah Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rekah Pharmaceutical has no effect on the direction of Bank of America i.e., Bank of America and Rekah Pharmaceutical go up and down completely randomly.
Pair Corralation between Bank of America and Rekah Pharmaceutical
Considering the 90-day investment horizon Bank of America is expected to generate 0.48 times more return on investment than Rekah Pharmaceutical. However, Bank of America is 2.08 times less risky than Rekah Pharmaceutical. It trades about 0.26 of its potential returns per unit of risk. Rekah Pharmaceutical Industry is currently generating about 0.02 per unit of risk. If you would invest 3,968 in Bank of America on August 29, 2024 and sell it today you would earn a total of 817.50 from holding Bank of America or generate 20.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 67.44% |
| Values | Daily Returns |
Bank of America vs. Rekah Pharmaceutical Industry
Performance |
| Timeline |
| Bank of America |
| Rekah Pharmaceutical |
Bank of America and Rekah Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Rekah Pharmaceutical
The main advantage of trading using opposite Bank of America and Rekah Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Rekah Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rekah Pharmaceutical will offset losses from the drop in Rekah Pharmaceutical's long position.| Bank of America vs. Citigroup | Bank of America vs. Wells Fargo | Bank of America vs. Toronto Dominion Bank | Bank of America vs. JPMorgan Chase Co |
| Rekah Pharmaceutical vs. Kamada | Rekah Pharmaceutical vs. Bet Shemesh Engines | Rekah Pharmaceutical vs. Unitronics | Rekah Pharmaceutical vs. PCB Tec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges |